Martina Vulganová

Martina Vulganová is a prominent figure in Slovak healthcare policy, recently appointed as the head of the drug policy section at the Ministry of Health. She previously served as the director of the Health Care Implementation Agency, where she evaluated hospital funding plans under the recovery plan. Her new role puts her in a position of significant influence over pharmacoeconomic analyses crucial for determining which medications are covered by public health insurance. However, her dual role as a leader in drug policy and her ownership of a firm conducting analyses for pharmaceutical companies has raised concerns about potential conflicts of interest, as noted by the president of the Slovak Chamber of Pharmacists.